出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年10月
ポピュレーション・ヘルス・マネジメント（PHM）市場：コンポーネント (ソフトウェア、サービス)、展開モード (オンプレミス、クラウドベース)、エンド ユーザー ［医療提供者 (病院、ACO)、医療保険者、雇用主グループ、政府機関］ – 2027 年までの世界予測
Population Health Management (PHM) Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) – Global Forecast to 2027
| ページ数 | 201 |
| 図表数 | 157 |
| 種別 | 英文調査報告書 |
| 価格 |
MarketsandMarkets（マーケッツアンドマーケッツ）「ポピュレーション・ヘルス・マネジメント（PHM）市場：コンポーネント (ソフトウェア、サービス)、展開モード (オンプレミス、クラウドベース)、エンド ユーザー ［医療提供者 (病院、ACO)、医療保険者、雇用主グループ、政府機関］ – 2027 年までの世界予測 – Population Health Management (PHM) Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) – Global Forecast to 2027」は世界のポピュレーションヘルスマネジメント（PHM）市場を調査し、主要セグメント毎に行った分析・予測結果を提供します。
The global population health management market is projected to reach USD 53.3 billion by 2027 from USD 27.8 billion in 2022, at a CAGR of 13.9% during the forecast period. Growth in this market is driven by the growing government initiatives to improve community health, increasing patient pool, rising geriatric population and the growing need to curtail healthcare costs. However, lack of skilled IT professionals & high infrastructural investments are expected to restrain the growth of this market to a certain extent.
“The software segment is projected to be the largest segment& register the highest growth in the population health management market, by component”
Based on the component, the software segment is projected to be the largest segment& register the highest growth during the forecast period. Factors responsible for the growth of this segment is the increased adoption of software pertaining to improved operational efficiency, no upfront capital investment for hardware, enhanced patient engagement.
“Healthcare Providers was the largest segment by the end user of population health management market in 2021”
Healthcare providers segment is projected to grow at the highest growth rate in the population health management market in 2021. Growing need to curtail healthcare costs, rising need for better financial outcomes, ACA mandates is expected to drive the demand for population health management services in the coming years.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, growing medical tourism, government initiatives for the adoption of HCIT, increasing healthcare expenditure, and the rising purchasing power of consumers will also propel market growth.
The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1:40%, Tier 2: 35%, and Tier 3: 25%
• By Designation – C-level: 25%, Director-level: 55%,and Others: 20%
• By Region – North America: 40%,Europe: 25%,AsiaPacific: 20%, Latin America: 10%,and Middle East & Africa: 5%.
Key players in the Population Health Management Market
The key players operating in the population health management market includeCerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US).
Research Coverage:
The report analyses the population health management market and aims to estimate the market size and future growth potential of various market segments, based on components, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.
目次
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.2.2 MARKETS COVERED 25
FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET 25
FIGURE 2 REGIONAL SEGMENTS COVERED 25
1.2.3 YEARS CONSIDERED 25
1.3 CURRENCY CONSIDERED 26
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 26
1.4 STAKEHOLDERS 26
1.5 LIMITATIONS 26
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 3 RESEARCH DESIGN 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 4 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Insights from primary experts 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS) 34
FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS) 35
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 36
2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS) 37
FIGURE 9 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 10 DATA TRIANGULATION METHODOLOGY 38
2.4 RESEARCH ASSUMPTIONS 39
2.5 RISK ASSESSMENT 39
TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET 39
3 EXECUTIVE SUMMARY 40
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 40
FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION) 41
FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 41
FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT 42
4 PREMIUM INSIGHTS 44
4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW 44
FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET 44
4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021) 45
FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021 45
4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022−2027) 47
FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD 47
4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 47
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS 48
FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 49
5.2.1.1 Government mandates and support for healthcare IT solutions 49
5.2.1.2 Need to curtail escalating healthcare costs 51
FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION) 51
5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden 52
5.2.2 RESTRAINTS 52
5.2.2.1 High investments in infrastructure to set up robust PHM program 52
5.2.2.2 Rising data breach concerns 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Growing importance of emerging markets in healthcare sector 54
5.2.3.2 Rising focus on personalized medicine 55
5.2.3.3 Increasing focus on value-based medicine 55
5.2.4 CHALLENGES 56
5.2.4.1 Lack of data management capabilities and skilled analysts 56
5.2.4.2 Interoperability issues 56
6 INDUSTRY INSIGHTS 57
6.1 INDUSTRY TRENDS 57
6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION 57
6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS 57
6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE 58
FIGURE 22 VALUE-BASED CARE WORKFLOW 59
6.1.4 CLOUD-BASED IT SOLUTIONS 59
6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS 60
6.2 ECOSYSTEM ANALYSIS 60
FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS 61
6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM 61
6.3.1 INTRODUCTION 61
FIGURE 24 ACOS: REIMBURSEMENT MODEL 61
6.3.2 US: EVOLUTION OF ACOS 62
FIGURE 25 EVOLUTION OF ACO MODELS 63
6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE 63
FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE 63
6.4 HCIT EXPENDITURE ANALYSIS 64
6.4.1 NORTH AMERICA 64
TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY 64
6.4.2 EUROPE 65
6.4.3 ASIA PACIFIC 65
TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING 65
TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING 66
6.5 REGULATORY ANALYSIS 66
6.5.1 NORTH AMERICA 66
6.5.2 EUROPE 68
6.5.3 ASIA PACIFIC 68
6.6 PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET 69
TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 69
6.7 PATENT ANALYSIS 70
FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022) 71
FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017–SEPTEMBER 2022) 72
6.8 ADJACENT MARKET ANALYSIS 72
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW 73
FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW 74
6.9 CASE STUDY 74
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA 75
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS 75
TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%) 75
6.10.2 BUYING CRITERIA 75
FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES 76
TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES 76
6.11 KEY CONFERENCES AND EVENTS (2022-2023) 76
6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET 77
6.13 PRICING ANALYSIS 78
6.13.1 INITIAL FEES 78
TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS 78
6.13.2 ANNUAL MAINTENANCE FEES 78
TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS 78
6.14 TECHNOLOGY ANALYSIS 78
6.14.1 INTEGRATION OF AI AND ML 78
6.14.2 DATA ANALYTICS 79
7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT 80
7.1 INTRODUCTION 81
TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 81
7.2 SOFTWARE 81
7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT 81
TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS 82
TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
7.3 SERVICES 85
7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET 85
TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS 86
TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY 88
8.1 INTRODUCTION 89
TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 89
8.2 ON-PREMISE MODE OF DELIVERY 89
8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION 89
TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS 90
TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 90
8.3 CLOUD-BASED MODE OF DELIVERY 91
8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 91
TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS 92
TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 92
9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER 93
9.1 INTRODUCTION 94
TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 94
9.2 HEALTHCARE PROVIDERS 94
9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET 94
TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 95
9.3 HEALTHCARE PAYERS 96
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS 96
TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION) 96
9.4 OTHER END USERS 97
TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD MILLION) 98
10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION 99
10.1 INTRODUCTION 100
TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION,
2020–2027 (USD MILLION) 100
10.2 NORTH AMERICA 101
FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 101
TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 102
TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 102
TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 103
10.2.1 US 103
10.2.1.1 US to dominate North American market during forecast period 103
TABLE 31 US: MACROECONOMIC INDICATORS 104
TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 104
TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 104
TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 105
10.2.2 CANADA 105
10.2.2.1 Deployment of digital health initiatives to boost market 105
TABLE 35 CANADA: MACROECONOMIC INDICATORS 106
TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 106
TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 106
TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 107
10.3 EUROPE 107
TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019 108
TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 109
TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 109
TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 110
10.3.1 GERMANY 110
10.3.1.1 Germany to dominate European population health management market 110
TABLE 44 GERMANY: MACROECONOMIC INDICATORS 111
TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 111
TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 112
TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 112
10.3.2 UK 112
10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions 112
TABLE 48 UK: MACROECONOMIC INDICATORS 114
TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 114
TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 114
TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 115
10.3.3 FRANCE 115
10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market 115
TABLE 52 FRANCE: MACROECONOMIC INDICATORS 116
TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 116
TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 117
TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 117
10.3.4 ITALY 117
10.3.4.1 Government initiatives to support market 117
TABLE 56 ITALY: MACROECONOMIC INDICATORS 118
TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 118
TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 119
TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 119
10.3.5 SPAIN 119
10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions 119
TABLE 60 SPAIN: MACROECONOMIC INDICATORS 120
TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 121
TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 121
TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 121
10.3.6 REST OF EUROPE 122
TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 122
TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 122
TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 123
10.4 ASIA PACIFIC 123
FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 124
TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 125
TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 125
TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.4.1 JAPAN 126
10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021 126
TABLE 71 JAPAN: MACROECONOMIC INDICATORS 127
TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 127
TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 128
TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10.4.2 CHINA 128
10.4.2.1 Strong government support to propel market 128
TABLE 75 CHINA: MACROECONOMIC INDICATORS 129
TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 129
TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 130
TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 130
10.4.3 INDIA 130
10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market 130
TABLE 79 INDIA: MACROECONOMIC INDICATORS 131
TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 131
TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 132
TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 132
10.4.4 REST OF ASIA PACIFIC 132
TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 133
TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 133
TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 134
10.5 LATIN AMERICA 134
10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS 134
TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 135
TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 135
TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 136
10.6 MIDDLE EAST & AFRICA 136
10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET 136
TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 137
TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 137
TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 137
11 COMPETITIVE LANDSCAPE 138
11.1 INTRODUCTION 138
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 138
FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022 139
11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE 140
FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021) 140
11.4 REVENUE ANALYSIS OF KEY PLAYERS 140
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021) 141
11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 141
FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX 141
11.6 COMPANY EVALUATION QUADRANT 142
11.6.1 STARS 142
11.6.2 EMERGING LEADERS 142
11.6.3 PERVASIVE PLAYERS 142
11.6.4 PARTICIPANTS 143
FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020 143
11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES 144
11.7.1 PROGRESSIVE COMPANIES 144
11.7.2 RESPONSIVE COMPANIES 144
11.7.3 DYNAMIC COMPANIES 144
11.7.4 STARTING BLOCKS 144
FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES 145
11.8 KEY PLAYERS ANALYSIS 145
TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE 146
11.9 COMPETITIVE SITUATIONS AND TRENDS 148
11.9.1 PRODUCT LAUNCHES 148
11.9.2 DEALS 148
11.9.3 OTHER DEVELOPMENTS 150
12 COMPANY PROFILES 151
12.1 KEY PLAYERS 151
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 CERNER CORPORATION 151
TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW 151
FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021) 152
12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS 157
TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW 157
FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021) 158
12.1.3 IBM CORPORATION 162
TABLE 95 IBM CORPORATION: COMPANY OVERVIEW 162
FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021) 163
12.1.4 EPIC SYSTEMS CORPORATION 165
TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 165
12.1.5 KONINKLIJKE PHILIPS 168
TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 168
FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021) 169
12.1.6 I2I POPULATION HEALTH 172
TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW 172
12.1.7 HEALTH CATALYST 175
TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW 175
FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021) 175
12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP) 178
TABLE 100 OPTUM, INC: COMPANY OVERVIEW 178
FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021) 178
12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES) 180
TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW 180
12.1.10 ECLINICALWORKS 181
TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW 181
12.1.11 HEALTHEC, LLC 183
TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW 183
12.1.12 MEDECISION 185
TABLE 104 MEDECISION: COMPANY OVERVIEW 185
12.1.13 ARCADIA 187
TABLE 105 ARCADIA: COMPANY OVERVIEW 187
12.1.14 ATHENAHEALTH 189
TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW 189
12.1.15 COTIVITI (VERSCEND TECHNOLOGIES) 191
TABLE 107 COTIVITI: COMPANY OVERVIEW 191
12.1.16 NEXTGEN HEALTHCARE, INC. 192
TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW 192
FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021) 192
12.2 OTHER PLAYERS 194
12.2.1 CONIFER HEALTH SOLUTIONS 194
12.2.2 SPH ANALYTICS 194
12.2.3 LIGHTBEAM HEALTH SOLUTIONS 195
12.2.4 INNOVACCER 195
12.2.5 LUMERIS 196
12.2.6 ZEOMEGA 196
12.2.7 HGS HEALTHCARE, LLC 197
12.2.8 PERSIVIA 197
12.2.9 COLOR HEALTH, INC. 198
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 199
13.1 DISCUSSION GUIDE 199
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 202
13.3 AVAILABLE CUSTOMIZATIONS 204
13.4 RELATED REPORTS 204
13.5 AUTHOR DETAILS 205